Details

NameSymbolSector
SOLARA ACTIVE PHARMA SCIENCES LIMITEDSOLARAPharmaceuticals
Open
605.1
High
621
Low
604
Close
616.1
Volume
136292
Exchange
nse
Time
03-Oct-2025

Outlook

Score:

2.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofSolaraActivePharmaSciencesis
None
EstimatedStoplossofSolaraActivePharmaSciencesis
604
SolaraActivePharmaScienceshasa
Bullishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofSolaraActivePharmaSciencesis
Unpredictableℹ
.

Trend

SolaraActivePharmaSciencesisin
Sideways trendℹ
.
PriceofSolaraActivePharmaSciencesis
Downℹ
by

4.16

%.
Target
Buy@

579

Sell@

709.02

Current@

616.1

Volume

ThetradevolumesofSolaraActivePharmaScienceshavebecome
Deficientℹ
ThevolumetrendforSolaraActivePharmaSciencesis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofSolaraActivePharmaSciencesis

Down

by

10.69

%

Valuation

ThecurrentmarketpriceofSolaraActivePharmaSciencesis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth2231crandtotalassetsworth2231cr,thebalancesheetofSolaraActivePharmaSciencesis:
Balancedℹ
.
Cashflow
SolaraActivePharmaScienceshas
Insufficientℹ
cashflowbecausethereis

Shortage

of

₹ 4cr

.Itis
Downℹ
by

0

%.
49.53% i.e. ₹ 212cr earned in operatingℹ
8.41% i.e. ₹ 36cr spent in investingℹ
42.06% i.e. ₹ 180cr spent in financingℹ
0% in otherℹ
SolaraActivePharmaScienceshas
Insufficientℹ
cashflowbecauseitis

₹ 0cr

.Itis
Upℹ
by

100

%.
50% i.e. ₹ 108cr earned in operatingℹ
1.39% i.e. ₹ 3cr spent in investingℹ
48.61% i.e. ₹ 105cr spent in financingℹ
0% in otherℹ
Income
TheincomeofSolaraActivePharmaSciencesis

₹ 320cr

and

Profit

is:

₹ 10cr

SolaraActivePharmaSciencesProfitisupby:

600

%andIncomeisUpby:

15.11

%
TheincomeofSolaraActivePharmaSciencesis

₹ 278cr

and

Loss

is:

₹ 2cr

SolaraActivePharmaSciencesLossesincreasedby:

125

%andIncomeisDownby:

7.64

%
TheincomeofSolaraActivePharmaSciencesis

₹ 301cr

and

Profit

is:

₹ 8cr

SolaraActivePharmaSciencesProfitisupby:

0

%andIncomeisDownby:

13.26

%
By using this site you agree to the use of cookies to deliver a better site experience.